Autres langues GSK plc

Actions

GSK

GB00BN7SWP63

Produits pharmaceutiques

Temps réel estimé 14:58:23 24/08/2026 Varia. 5j. Varia. 1 janv.
1 894,00 GBX -1,28% Graphique intraday de GSK plc +2,46% +3,97%

Autres langues

13:52 GSK plc Announces Jemperli Accepts for Priority Review by US FDA for dMMR/MSI-H Locally Advanced Rectal Cancer
11:20 Gsk plc Announces Approval of Hibsago (Bepirovirsen) in Japan as First Functional Cure for Chronic Hepatitis B
11:11 GSK Obtains First Global Approval for Chronic Hepatitis B Drug Hibsago
10:21 GSK gets hepatitis approval in Japan, fast US review in rectal cancer
10:08 GSK Says Chronic Hepatitis B Treatment Approved in Japan
09:29 GSK Says Jemperli Accepted for Priority Review as Potential Treatment for Rectal Cancer
09:06 GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy
09:00 GSK drug approved in Japan; Tracsis trading in-line
08:59 FDA prüft Darmkrebsmedikament Jemperli von GSK vorrangig
08:35 GSK's Rectal Cancer Drug Jemperli Accepted for Priority Review by FDA
08:31 GSK's Hibsago Wins Japanese Approval for Chronic Hepatitis B Treatment
08:25 US FDA Accepts GSK's Supplemental Application for Rectal Cancer Drug for Priority Review
08:16 GSK : Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B
08:08 GSK : Jemperli (dostarlimab) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer
21/08 WINNERS & LOSERS: Hunting falls on outlook cut; miners rise
20/08 Pharma sector doubles down on AI amid hopes of slashing costs, timelines
20/08 Cancer vaccines finally garner the spotlight
18/08 Chugai grants GSK exclusive global license for AID351 dengue antibody
17/08 FTSE 100 drifts lower as oil price pushes higher
17/08 European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
17/08 GSK Kept at Hold as Berenberg Notes Cost Savings Plan
17/08 Sandoz to license three biosimilar drugs from Shanghai Henlius Biotech
14/08 FTSE 100 drifts lower in mixed day for Europe
14/08 FTSE 100 underwhelms in tepid end to week
14/08 WINNERS & LOSERS: Michael Page higher on UBS lift; software shares up
Aucun résultat pour cette recherche